Get started
Author

Sara Ratia

Observed institution: Karius, Inc. (United States)
ORCID: 0009-0003-2813-1061
Observed ORCID: 0009-0003-2813-1061
OpenAlex ID: A5116207579
Mast cell depletion and repopulation dynamics define briquilimab efficacy in a mouse model of allergic asthma
2026 · Mang Yu, Sara Ratia, et al. · Journal of Allergy and Clinical Immunology · 3
Human KIT Antibody Briquilimab Diminishes Anaphylactic Responses in Mice Expressing Chimeric Human‐Mouse KIT
2025 · Hye‐Sook Kwon, Song Eun Lee, et al. · Allergy · 3
PDF
Briquilimab, an Anti-Human CD117 Antibody, Treats Low-Calcemic Vitamin D3 Analog MC903-Induced Dermatitis in Mouse Model Expressing Chimeric Human/Mouse CD117
2025 · Sambidhan Kattel, Sara Ratia, et al. · Journal of Allergy and Clinical Immunology
PDF
Briquilimab, an Anti-Human CD117 Antibody, Prevents Epicutaneous Oxazolone-Induced Features of Dermatitis in Mouse Model Expressing Chimeric Human/Mouse CD117
2025 · Andrew Wells, Sambidhan Kattel, et al. · Journal of Allergy and Clinical Immunology
Works count: 4
Citation count: 6
H-index: 2
I10-index:
Year
Topic
Type